Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study ; volume:21 ; number:1 ; day:31 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
BMC medicine ; 21, Heft 1 (31.10.2023), 1-11, 12.2023
- Creator
-
Luo, Shan
Lam, Hugh Simon
Chan, Yap Hang
Tang, Clara Sze Man
He, Baoting
Kwok, Man Ki
Leung, Gabriel M.
Schooling, C Mary
Au Yeung, Shiu Lun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12916-023-03115-y
- URN
-
urn:nbn:de:101:1-2024011720595082786986
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Luo, Shan
- Lam, Hugh Simon
- Chan, Yap Hang
- Tang, Clara Sze Man
- He, Baoting
- Kwok, Man Ki
- Leung, Gabriel M.
- Schooling, C Mary
- Au Yeung, Shiu Lun
- SpringerLink (Online service)
Other Objects (12)
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Common Methods for Performing Mendelian Randomization
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
Common Methods for Performing Mendelian Randomization
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Identification of lipid-modifying drug targets for autoimmune diseases: insights from drug target mendelian randomization
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study